Two Sigma Investments’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,868
| Closed | -$12.2K | – | 3608 |
|
|
2024
Q4 | $12.2K | Sell |
22,868
-24,797
| -52% | -$17.3K | ﹤0.01% | 3124 |
|
|
2024
Q3 | $83.9K | Buy |
+47,665
| New | +$66.5K | ﹤0.01% | 2917 |
|
|
2024
Q2 | – | Sell |
-42,834
| Closed | -$387K | – | 3447 |
|
|
2024
Q1 | $387K | Buy |
42,834
+1,629
| +4% | +$15.8K | ﹤0.01% | 2446 |
|
|
2023
Q4 | $448K | Sell |
41,205
-12,900
| -24% | -$96.7K | ﹤0.01% | 2514 |
|
|
2023
Q3 | $436K | Sell |
54,105
-168,379
| -76% | -$1.4M | ﹤0.01% | 2335 |
|
|
2023
Q2 | $2.42M | Buy |
+222,484
| New | +$1.91M | 0.01% | 1313 |
|
|
2022
Q3 | – | Sell |
-51,325
| Closed | -$248K | – | 2929 |
|
|
2022
Q2 | $248K | Buy |
51,325
+28,409
| +124% | +$173K | ﹤0.01% | 2089 |
|
|
2022
Q1 | $214K | Buy |
+22,916
| New | +$228K | ﹤0.01% | 2322 |
|
|
2021
Q3 | – | Sell |
-59,292
| Closed | -$1.06M | – | 4852 |
|
|
2021
Q2 | $1.06M | Sell |
59,292
-576
| -1% | -$9.27K | ﹤0.01% | 2421 |
|
|
2021
Q1 | $927K | Sell |
59,868
-5,732
| -9% | -$82.9K | ﹤0.01% | 2394 |
|
|
2020
Q4 | $800K | Buy |
65,600
+49,299
| +302% | +$687K | ﹤0.01% | 2172 |
|
|
2020
Q3 | $209K | Sell |
16,301
-135,523
| -89% | -$1.17M | ﹤0.01% | 2800 |
|
|
2020
Q2 | $1.54M | Buy |
151,824
+86,301
| +132% | +$794K | 0.01% | 1243 |
|
|
2020
Q1 | $532K | Buy |
65,523
+28,879
| +79% | +$250K | ﹤0.01% | 1883 |
|
|
2019
Q4 | $317K | Buy |
+36,644
| New | +$206K | ﹤0.01% | 3153 |
|
Two Sigma Investments's MRNS Position: Q1 2025 in Review
Two Sigma Investments sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 22,868 shares — an estimated $12.2K sold.
Two Sigma Investments first reported a position in MRNS in Q4 2019 and held it in 15 quarters. The position peaked at $2.42M in Q2 2023. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.
- Two Sigma Investments reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
- Two Sigma Investments sold 22,868 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $12.2K.
- Two Sigma Investments first reported a position in Marinus Pharmaceuticals, Inc in Q4 2019 and held it in 15 quarters.
- Two Sigma Investments's Marinus Pharmaceuticals, Inc position peaked at $2.42M in Q2 2023.
- 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.